Meet 10 new speakers at Asia PE-VC Summit 2024 - Super Saver Tickets Extended!
Our new speakers operate across geographies including Greater China, India, Southeast Asia and the Middle East.
Stay updated with breaking news from Quadria Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Our new speakers operate across geographies including Greater China, India, Southeast Asia and the Middle East.
Quadria, which is currently raising an $800-million fund to invest in healthcare opportunities across India and Asia, has assets under management of $1.4 billion in India.
NephroPlus operates about 450 dialysis centres in three main countries namely India, the Philippines and Uzbekistan.
India Business News: New Delhi: Singapore-based healthcare-focused PE firm Quadria Capital has announced an investment of $102 million (Rs 850 crore) in NephroPlus, Asia's.
NephroPlus, India's largest dialysis chain, has secured $103 million (₹860 crore) in a Series F funding round led by Quadria Capital. This funding, a mix of fresh capital and a secondary sale, aims to drive expansion plans within India and targeted markets overseas. The primary component of the funding is ₹100 crore. Quadria Capital will become a minority shareholder, valuing NephroPlus at over ₹2,000 crore. Existing investors like Bessemer Venture Partners, International Finance Corporation, and IIFL also participated in the funding round, reducing their stakes.